Zenacts Pharma Pvt Ltd | FAVIVOX FAVIPIRAVIR-400 MG | Favipiravir for COVID-19 treatment | Allopathic Drug Manufacturing

Buiz.in / Allopathic Drug Manufacturing / Coronovirus Treatment / Panchkula / Zenacts Pharma Pvt Ltd

Zenacts Pharma Pvt Ltd is a Panchkula based pharmaceutical company offering a wide range pharma products for the corona-virus treatment like FAVIVOX FAVIPIRAVIR-400 mg and also protection kits including facemasks, sanitizers, immunity boosters, PPE kits etc. Contact Zenacts Pharma Pvt Ltd for franchise / wholesale product inquiry.

PCD Pharma Franchise Business in India: Scope & Opportunities

We all know that India is one of the world's fastest expanding economies. There is a rise in demand as the population and economy grow, and the pharmaceutical business is the clearest illustration of this. The Indian pharmaceutical industry is quickly expanding, providing strong economic opportunities for pharmaceutical specialists.

For many pharma experts, the PCD Pharma Franchise business opportunity has surfaced as a fantastic business option since it does not involve much investment and provides a fair return without putting them under any type of job pressure. With the increasing heal

Company Particulars

Company ID

216

Company Name

Zenacts Pharma Pvt Ltd

Contact Person

Manager

Address

Plot No. 198, Basement & First Floor, Ind. Area, Phase -2,

Town

Panchkula

District

Ambala

State

Haryana

Country

India

Post Code

134113

Contact Details

Phone

+(91)-7696048889

Mobile

+(91)-9878941960

Whats App

+(91)-7696048889

Website

https://www.zenactspharma.com/category/coronavirus-treatment/

Digital Visiting Card

Manage

✍ Edit this page

FAVIVOX FAVIPIRAVIR-400 MG

Favipiravir, sold under the brand name 'FAVIVOX FAVIPIRAVIR-400 MG' among others, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections, including SARS-CoV-2. Like the experimental antiviral drugs T-1105 and T-1106, it is a pyrazinecarboxamide derivative. Contact Zenacts Pharma Pvt Ltd for franchise / wholesale product inquiry.

Favipiravir for COVID-19 treatment

Considering the approved status, evidence on the safety, and key indicators of efficacy of favipiravir in COVID-19 from trials/registries in Russia, Japan, China, and Thailand, it appears to be useful in the management of COVID-19, particularly mild to moderate disease; however, large randomised controlled trials are needed to demonstrate whether this effect translates to clinical benefits such as shorter disease course, early hospital discharge, and reduced nephrotoxicity. It is currently available for COVID-19 therapy in a number of countries, including Russia, Bangladesh, Pakistan, Jordan, Egypt, and Saudi Arabia. It is a promising treatment that has been repurposed to treat COVID-19 because of its quick viral clearance, greater clinical recovery rate, and availability as an oral medicine with a documented safety profile. Favipiravir's clinical effectiveness, safety, and therapeutic role in the overall treatment of COVID-19 will be further explored in current clinical trials across the globe. Contact Zenacts Pharma Pvt Ltd for franchise / wholesale product inquiry.